Literature DB >> 11790453

Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach.

Yun-Qing Bai1, Hiroshi Yamamoto, Yoshimitsu Akiyama, Hiroyuki Tanaka, Touichirou Takizawa, Morio Koike, Osmar Kenji Yagi, Kiyoshi Saitoh, Kimiya Takeshita, Takehisa Iwai, Yasuhito Yuasa.   

Abstract

The roles of CDX2 and CDX1 homeobox genes during gastric carcinogenesis remain poorly defined. We have studied the expression of CDX2/1 in gastric cancers and intestinal metaplasia (IM) of 69 gastric carcinoma patients by immunohistochemistry. CDX2/1 were shown to be ectopically overexpressed in IM in 41 (85%) of 48, and 47 (90%) of 52 cases, respectively. The expression of CDX2/1 was detected in 38 (55%) and 51 (74%) of the 69 gastric carcinomas, respectively. The histological type of the gastric carcinomas was independently associated with CDX2 expression, but not with that of CDX1, with higher CDX2 expression in intestinal type (differentiated type) than in diffuse type (undifferentiated type) gastric carcinomas. Our results thus suggest that CDX2 and CDX1 may play a role during IM formation and gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790453     DOI: 10.1016/s0304-3835(01)00753-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  58 in total

1.  Laparoscopic low anterior resection for hematogenous rectal metastasis from gastric adenocarcinoma: a case report.

Authors:  Sang Woo Lim; Jung Wook Huh; Young Jin Kim; Hyeong Rok Kim
Journal:  World J Surg Oncol       Date:  2011-11-11       Impact factor: 2.754

2.  CDX2 as a marker for intestinal differentiation: Its utility and limitations.

Authors:  Reda S Saad; Zeina Ghorab; Mahmoud A Khalifa; Mei Xu
Journal:  World J Gastrointest Surg       Date:  2011-11-27

3.  Initiation of trophectoderm lineage specification in mouse embryos is independent of Cdx2.

Authors:  Guangming Wu; Luca Gentile; Takuya Fuchikami; Julien Sutter; Katherina Psathaki; Telma C Esteves; Marcos J Araúzo-Bravo; Claudia Ortmeier; Gaby Verberk; Kuniya Abe; Hans R Schöler
Journal:  Development       Date:  2010-12       Impact factor: 6.868

Review 4.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

5.  Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma.

Authors:  Artit Jinawath; Yoshimitsu Akiyama; Yasuhito Yuasa; Chawalit Pairojkul
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-23       Impact factor: 4.553

6.  Altered expression of CDX-2, PDX-1 and mucin core proteins in "Ulcer-associated cell lineage (UACL)" in Crohn's disease.

Authors:  Yasunori Kaneko; Takamichi Nakamura; Masayoshi Hayama; Noriko Hosaka; Taiji Akamatsu; Hiroyoshi Ota
Journal:  J Mol Histol       Date:  2007-10-24       Impact factor: 2.611

7.  siRNA targeting of Cdx2 inhibits growth of human gastric cancer MGC-803 cells.

Authors:  Xiao-Tong Wang; Yu-Bo Xie; Qiang Xiao
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

8.  Cell lineage dynamics in the process leading to intestinal metaplasia.

Authors:  Hirotsugu Sakamoto; Hiroyuki Mutoh; Hiroko Hayakawa; Miho Sashikawa; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2011-03-08       Impact factor: 7.527

9.  The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray.

Authors:  Mi Jin Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

10.  Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.

Authors:  Tsutomu Mizoshita; Tetsuya Tsukamoto; Hayao Nakanishi; Ken-ichi Inada; Naotaka Ogasawara; Takashi Joh; Makoto Itoh; Yoshitaka Yamamura; Masae Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.